PUBLIKACJE NAUKOWE

PRACE OPUBLIKOWANE W 2021 ROKU

Autorzy

Tytuł pracy

Czasopismo

Kategoria

IF 2020

MNiSW 2021

1.

Pasek M., Suchocka L., Osuch-
Pęcak
G., Muzykiewicz K., Iwańska E., Kaducakowa H., Goździalska A., Goździalska M.

Longitudinal Health-Related Quality of Life Study among Cervical Cancer Patients Treated with Radiotherapy

Journal of Clinical Medicine 2021, 10(2), 226

DOI: 10.3390/jcm10020226

A

4.241

140

2.

Spałek M.J., Poleszczuk J., Czarnecka A.M., Dudzisz-Sledź M., Napieralska A., Matysiakiewicz J., Chojnacka M., Raciborska A., Sztuder A., Maciejczyk A., Szulc A., Skóra T., Cybulska-Stopa B., Winiecki T., Kaźmierska J., Tomasik B., Fijuth J., Rutkowski P.

Radiotherapy in the Management of Pediatric and Adult Osteosarcomas:
A Multi-Institutional Cohort Analysis

Cells 2021, 10, 366

DOI: 10.3390/cells10020366

A

6.600

140

3.

Gajewski J., Garbacz M., Chang Ch.-W. , Czerska K., Durante M., Krah N., Krzempek K., Kopeć K., Lin L., Mojżeszek N., Patera V., Pawlik-Niedźwiedka M., Rinaldi I., Rydygier M., Pluta E., Scifoni M., Skrzypek A., Tomasino F., Schiavi A., Ruciński A.

Commissioning of GPU-Accelerated Monte Carlo Code FRED for Clinical Applications in Proton Therapy

Frontiers in Physics 2021,8: 567300

DOI: 10.3389/fphy.2020.567300

A

3.560

20

4.

McDougall L.I., Powell R.M., Ratajska M., Lynch-Sutherland Ch.F., Hossain S.M., Wiggins G.A.R., Harazin-Lechowska A., Cybulska-Stopa B., Motwani J., Macaulay E.C., Reid G., Walker R.C., Ryś J., Eccles M.R.

Differential Expression of BARD1 Isoforms in Melanoma

Genes 2021, 12, 320

DOI: 10.3390/genes12020320

A

4.096

100

5.

Łuczyńska E., Pawlak M., Piegza T., Popiela T J., Heinze S., Dyczek S., Rudnicki W.

Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging

Ginekologia Polska 2021, 92, 2: 92-97

DOI: 10.5603/GP.a2020.0169

A

1.232

40

6.

Łukomska A., Menkiszak J., Gronwald J., Tomiczek-Szwiec-J., Szwiec M, Jasiówka M., Blecharz P., Kluz T., Stawicka-Niełacna M., Mądry J., Białkowska K., Prajzendanc K., Kluźniak W., Cybulski C., Dębniak T., Huzarski T., Tołoczko-Grabarek A., Byrski T., Baszuk P., Narod St.A., Lubiński J., Jakubowska A.

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

Cancers 2021, 13, 4: 849

DOI: 10.3390/cancers13040849

A

6.639

140

7.

McDermott D.F., Lee J-L, Ziobro M., Suarez C., Langiewicz P., Matveev V.B., Wiechno P., Gafanov R.A., Tomczak P., Puliot F., Donskov F., Alekseev B.Y., Shin N.J., Bjarnason G.A., Castellano D., Silverman R.K., Perini R.F., Schloss Ch., Atkins M.B.

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

Journal of Clinical Oncology 2021, 39, 9: 1029-1039

DOI: 10.1200/JCO.20.02365

A

44.544

200

8.

Stiller Ch.A., Botta L., Sanchez Perez M.J., Lopez M.D.Ch., Marcos-Gragera R., Scuderi T., Huws D.W., Trama A., the RARECARENet WG w tym
Rachtan J.

Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet)

Cancer Epidemiology 2021, 70, 101877

DOI:10.1016/j.canep.2020.101877

A

2.984

100

9.

Rudnicki W., Piegza T., Rozum-Liszewska N., Górski M., Popiela T J.., Basta P., Heinze S., Łuczyńska E.

The effectiveness of contrast-enhanced spectral mammography and magnetic resonance imaging in dense breasts

Polish Journal of Radiology 2021, 86: e159-e164

DOI: 10.5114/pjr.2021.104834

A

10.

Słonina D., Kabat. D., Biesaga B., Janecka-Widła A., Szatkowski W.

Chemopotentiating effects of low-dose fractionated radiation on cisplatin and paclitaxel in cervix cancer cell lines and normal fibroblasts from patients with cervix cancer

DNA Repair 2021, 103: 103113

DOI:10.1016/j.dnarep.2021.103113

A

4.913

140

11.

Sitarz K., Czamara K., Bialecka J., Klimek M., Szostek S., Kaczor A.

Dual Switch in Lipid Metabolism in Cervical Epithelial Cells during Dysplasia Development Observed Using Raman Microscopy and Molecular Methods

Cancers 2021, 13, 1997

DOI: 10.3390/cancers13091997

A

6.639

140

12.

Jurczak W., Rule S., Townsend W., Tucker D., Sarholz B., Scheele J., Dyroff M., Gribben J.G., Długosz-Danecka M., Zinzani L

Phase I, first-in-human trial of Bruton’s tyrosine kinase inhibitor M7583 in patients with B-cell malignancies

Leukemia & Lymphoma 2021, 24

DOI: 10.1080/10428194.2021.1913139

A

3.280

70

13.

Brodziak A., Sigorski D., Osmola M., Wilk M., Gawlik-Urban A., Kiszka J., Machulska-Ciuraj K., Sobczuk P.

Attitudes of Patients witch Cancer towards Vaccinations – Results of Online Survey with Special Focus on the Vaccination against COVID-19

Vaccines 2021, 9, 411

DOI: 10.3390/vaccines9050411

A

4.422

140

14.

Evans D.G., Philips K.A., Milne R.L., Fruscio R.L., Cybulski C., Gronwald J., Lubiński J., Huzarski T., Hyder Z., Forde C., Metcalfe K., Senter L., Weitzel J., Tung N., Zakalik D., Ekholm M., Sun P., Narod S.A., kConFAB Investigators, Polish Hereditary Breast Cancer Consortium, Hereditary Breast Cancer Clinical Study Group; w tym Ryś J.

Survival from breast cancer in women with BRCA2 mutation by treatment

British Journal of Cancer 2021, 124:1524-1532

DOI; 10.1038/s41416-020-01164-1

A

7.640

140

15.

Moran J.M.T, Biecek P., Donizy P., Wu Ch.L., Kopczyński J., Pieniążek M., Ryś J., Hoang M.P.

Large nuclear size correlated with better overall survival, Merkel cell polyomavirus positivity, and terminal deoxynucleotidyl transferase expression in Merkel cell carcinoma

Journal of the American Academy of Dermatology 2021, 84 (2):
550-552

DOI: 10.1016/j.jaad.2020.05.125

E

11.527

140

16.

Donizy P., Wróblewska J.P., Dias-Santagata D., Woznica K., Biecek P., Mochel M.C., Wu Ch.-L., Kopczyński J., Pieniążek M., Ryś J., Marszalek A., Hoang M.P.

Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles

Cancers 2021, 13: 1621

DOI: 10.3390/cancers13071621

A

6.639

140

17.

Dumanski J.P., Halvardson J.,
Davies H., Rychlicka-Buniowska E., Mattisson J., Moghadam B.T., Nagy N., Węglarczyk K., Bukowska-Strakova K., Danielsson M., Olszewski P., Piotrowski A., Oerton E., Ambicka A., Przewoźnik M., Bełch Ł., Grodzicki T., Chłosta P.L., Imreh S., Giedraitis V., Kilander L., Nordlund J., Ameur A., Gyllensten U., Johansson A., Józkowicz A., Siedlar M., Klich-Rączka A., Jaszczyński J., Enroth S., Baran J., Ingelsson M., Perry J.R.B., Ryś J., Forsberg L.A.

Immune cells lacking Y chromosome show dysregulation of autosomal gene expression

Cellular and Molecular Life Science 2021, 78: 4019-4033

DOI: 10.1007/s00018-021-03822-w

A

9.261

140

18.

Wojciechowski P., Wilson K., Nazir J., Pustułka I., Tytuła A., Smela B., Pochopień M., Vredenburg M., McCrae K.R., Jurczak W.

Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis

Advances in Therapy, published online 01.05. 2021

DOI: 10.1007/s12325-021-01752-4

A

3.845

70

19.

Furman R., Byrd J.C., Owen R.G., O’Brien S.M., Brown J.R., Hillmen P., Stephens D.M., Chernyukhin N., Lezhava T., Hamdy A.M., Izumi R., Patel P., Baek M., Christian B., Dyer M.J.S, Streetly M.J., Sun C., Rule S., Wang M., Ghia P., Jurczak W., Pagel J.M., Sharman J.P

Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignancies

Leukemia, published online 04.2021

DOI:10.1038/s41375-021-01252-y

A

11.528

200

20.

Nowakowski G., Chiapella A., Gascoyne RD., Scott D. W., Zhang Q., Jurczak W., Oezcan M., Hong X., Zhu J., Jin. J., Belada D., Bergua J.M., Piazza F., Mocikova H., Molinari A., L., Yoon D.H., Cavallo F., Tani M., Yamamoto K., Izutsu K., Kato K., Czuczman M., Hersey S., Kilcoyne A., Russo J., Hudak K., Zhang J., Wade S., Witzig T., Vitolo U., on behalf of the ROBUST Trial Investigators

ROBUST: A Phase III Study of Lenalidomine Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients with ABC-Type Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology 2021, 39, 12: 1317-1328

DOI:10.1200/JCO.20.01366

A

44.544

200

21.

Hodkinson B.P., Schaffer M., Brody J.D., Jurczak W., Carpio C., Ben-Yehuda D., Avivi I., Forslund A., Oezcan M., Alvarez J., Ceulemans R., Fourneau N., Younes A., Balasubramanian S.

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter’s transformation

Translational Oncology 2021, 14: 100977

DOI: 10.1016/j.tranon.2020.100977

A

4.243

100

22.

Fowler N., Samaniego F., Jurczak W., Ghosh N., Derenzini E., Reeves J.A., Knopińska-Posłuszny W., Cheah Ch. Y., Philips T., Lech-Maranda E., Cheson B.D., Caimi P.F., Grosicki S., Leslie L.A., Chavez J.C., Fonseca G., Babu S., Hodson D.J., Shao S.H., Burke J.M., Sharman J.P., Law J.Y., Pagel J.M., Miskin H.P., Sportelli P., O’Connor O.A., Weiss M.S., Zinzani P.L

Umbralisib, a Dual PI3Kϐ/CK1 ε  Inhibitor in Patients with Relapsed or Refractory Indolent Lymphoma

Journal of Clinical Oncology 2021, 39, 15:1609-1618

 

DOI: 10.1200JCO.20.03433

A

44.544

200

23.

Mato A.R., Shah N.N., Jurczak W., Cheach Ch.Y., Pagel J.M., Woyach J.A., Fakhri B., EyereT., Lamanna N., Patel M.R., Alencar A., Lech-Maranda E., Wierda W.G., Coombs C.C., Gerson J.N., Ghia P., Le Gouill S., Lewis D.J., Sundaram S., Cohen J.B., Flinn I.W., Tam C.S., Barve M.A., Kuss B., Taylor J., Abdel-Wahab O., Schuster S.J., Lia Palomba M., Lewis K.L., Roeker L.E., Davids M.S., Ni Tan X., Fenska T.S., Wallin J., Tsai D.E., Ku N.C., Chen J., Yin M., Nair B., Ebata K., Marella N., Brown J.R., Wang M.

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase ½ study

Lancet 2021, 397:892-901
DOI:10.1016/S0140-6736(21)00224-5

A

79.321

200

24.

Matasar M.J., Capra M., Oezcan M., Lv F., Li W., Yanez E., Sapunarova K., Lin T., Jin J., Jurczak W., Hamed A., Wang M-Ch., Baker R., Bondarenko I., Zhang Q., Feng J., Geissler K., Lazaroiu M., Saydam G., Szomor A., Bouabdallah K., Galiulin R., Uchida T., Mongay Soler L., Cao A., Hiemeyer F., Mehra, Childs B.H., Shi Y., Zinzani P.L.,

Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma  (CHRONOS-3): a double – blind, randomized, placebo-controlled, phase 3 trial

Lancet 2021,
22: 678-689

DOI: 10.1016/S1470-2045(21)00145-5

A

79.321

200

25.

Giebel S., Basak G., Bieniaszewska M., Czerw T., Czyż A., Drozd-Sokołowska J., Dytfeld D., Giannopoulos K., Gil L., Helbig G., Hołowiecki J., Hus I., Jamroziak K., Jędrzejczak W.W., Jurczak W., Jurczyszyn A., Lech-Maranda E., Lewandowski K., Mądry K., Prochorec-Sobieszek M., Robak T., Sacha T., Sokołowska-Wojdyło M., Szymczyk M., Walewski J., Wierzbowska A., Wołowiec D., Wróbel T., Zaucha J.M., Styczyński J.

 

Current status and achievements of Polish haemato-oncology

Acta Haematoligica Polonica 2021, 1, 52: 4-17

DOI: 10.5603/AHP.2021.0003

D

26.

Wierdak M., Surmiak M., Milan-Ciesielska K., Rubinkiewicz M., Rzepa A., Wysocki M., Major P., Kłęk S., Pędziwiatr M.

Immunonutrition Changes Inflammatory response in Colorectal Cancer: Results from a Pilot Randomized Clinical Trial

Cancers 2021, 13, 1444

DOI: 10.3390/cancers 13061444

A

6.639

140

27.

Folwarski M., Kłęk S., Matras P., Bartoszewska L., Bednarz S., Jakubczyk M., Kamocki Z., Krasowski G., Kumecki M., Kwella B., Matyasik –Luśnia K., Matyasik K., Pierzynowska G., Szafrański W., Szopiński J., Urbanowicz K., Sobocki J.,

Organizational issues of home parenteral nutrition during COVID-19 pandemic: Results from multicenter, nationwide study

Nutrition 2021, 86, 111202

DOI: 10.1016/j.nut2021.111202

A

4.008

140

28.

Wysocki W.M., Grela-Wojewoda A., Jankowski M.

Fallen dogmas: recent advances in locoregionally advanced melanoma

Polish Archives of Internal Medicine 2021, 131, 5

DOI: 10.20452/pamw.15936

D

3.277

100

29.

Biesaga B., Kołodziej-Rzepa M., Janecka-Widła A., Słonina D., Halaszka K., Przewożnik M., Mucha-Małecka A.

Lack of CD44 overexpression and application of concurrent chemoradiotherapy with cisplatin independently indicate excellent prognosis in patients with HPV-positive oropharyngeal cancer

Tumor Biology 2021, 43: 99-113

DOI: 10.3233/TUB-200049

A

100

30.

Mucha-Małecka A., Biesaga B., Janecka-Widła A., Przewoznik M., Małecki K.

Assessment of HPV16 infection in patients with laryngeal cancer

Polish Journal of Pathology 2021, 72(1): 64-74

DOI: 10.5114/pjp.2021.104659

A

1.072

40

31.

Ghia P., Długosz-Danecka M., Scarfo L., Jurczak W.

Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia

Leukemia & Lymphoma 2021, 62, 5: 1066-1076

DOI: 10.1080/10428194.2020.1864352

D

3.280

70

32.

Wagner-Johnston N.D., Schuster S.J., deVos S., Salles G., Jurczak W.J., Flowers C.R., Viardot A., Flinn I.W., Martin P., Xing G., Rajakumaraswamy N., Gopal A.K.

Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas

Leukemia & Lymphoma 2021, 62, 5: 1077-1087

DOI: 10.1080/10428194.2020.1855344

A

3.280

70

33.

Salles G., Długosz-Danecka M., Ghesquiere H., Jurczak W.

Tafasitamab for the treatment of relapsed or refractowy diffuse large B-cell lymphoma

Expert Opinion on Biological Therapy 2021, 21, 4:455-463

DOI: 10.1080/14712598.2021.1884677

D

4.388

100

34.

Brzuszek B., Zielińska P., Prochon A., Jurczak W.

COVID-19 vaccine hesitancy among lymphoma patients in Poland

Acta Haematologica Polonica 2021, 52, 3: 202-206

DOI: 10.5603/AHP.2021.0041

A

35.

Mleko M., Pitynski K., Pluta E.,
Czerw A., Sygit K., Karakiewicz B., Banas T.

Role of Systemic Inflammatory Reaction in Female Genital Organ Malignancies – State of the Art

Cancer Management and Research 2021, 13: 5491-5508

DOI: 10.2147/CMAR.S312828

D

3.989

140